Preferred Name |
rivastigmine tartrate |
|
Synonyms |
Exelon |
|
Definitions |
The tartrate salt form of rivastigmine, a phenylcarbamate derivative exhibiting cognitive stimulating property. Although the mechanism of action has not been fully elucidated, rivastigmine tartrate may bind reversibly to cholinesterase, thereby decreasing the breakdown of acetylcholine and enhancing cholinergic function. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47707" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47707" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000779007 |
|
altLabel |
Exelon carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1) SDZ-ENA 713 |
|
CAS Registry |
129101-54-8 |
|
cui |
C0772415 C4083031 C0730987 |
|
DATE FIRST PUBLISHED |
2016-02-24 |
|
Date last modified |
2016-02-24 |
|
definition |
The tartrate salt form of rivastigmine, a phenylcarbamate derivative exhibiting cognitive stimulating property. Although the mechanism of action has not been fully elucidated, rivastigmine tartrate may bind reversibly to cholinesterase, thereby decreasing the breakdown of acetylcholine and enhancing cholinergic function. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47707" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47707" NCI Thesaurus) |
|
LT |
TRD |
|
NCI ID |
C47707 |
|
notation |
CDR0000779007 |
|
ORIG STY |
Drug/agent |
|
prefLabel |
rivastigmine tartrate |
|
tui |
T109 T121 |